Yamakawa S, Nomura T, Misumi Y, Taguchi T, Nakahara K, Tasaki M, Kuyama N, Usuku H, Izumiya Y, Takihara Y, Aldinc E, Obayashi K, Inoue T, Tsujita K, Ando Y, Ueda M. Development and validation of the modified-comprehensive Kumamoto Score: a multi-organ assessment tool for hereditary transthyretin amyloidosis. Amyloid. 2026:1-11.

Nomura T, Misumi Y, Ueda M. Clinical features of chronic inflammatory demyelinating polyneuropathy: a single-center experience with 33 patients. Front Neurol. 2026;17:1743650.

Kido J, Ueno H, Misumi Y, Sugawara K, Saito S, Koshimizu E, Matsumoto N, Ueda M, Nakamura K. Non-pterygium Escobar syndrome from compound-heterozygous CHRNG variants: genotype-phenotype insights. Hum Genome Var. 2026;13:8.

Fu L, Kim CA, Tokita M, Miyata Y, Okamoto N, Makita Y, Osaka H, Fujimoto A, Daida A, Nirei J, Udagawa N, Hayakawa S, Deguchi K, Fukuda M, Matsumoto H, Akasaka M, Okada J, Misumi Y, Kido J, Suzuki T, Aoi H, Seyama R, Hamanoue H, Mitsuhashi S, Ohori S, Saida K, Inoue Y, Hamanaka K, Tsuchida N, Uchiyama Y, Koshimizu E, Miyatake S, Mizuguchi T, Itakura A, Harada N, Fujita A, Matsumoto N. Completely resolved structural variants by optical genome mapping with adaptive sampling from CNV discovery. NPJ Genom Med. 2026;11:26.

Oh J, Sekijima Y, Mochizuki H, Joon Kim B, Min JH, Katsuno M, Yin Tan C, Lee YC, Misumi Y, Zhao W, Chan-Daniels A, Chao CC. Efficacy and Safety of Vutrisiran in Patients with Hereditary Transthyretin-mediated Amyloidosis with Polyneuropathy: Analysis of the East Asian Subpopulation from HELIOS-A. Neurol Ther. 2026;15:1065-1080.

Yoshimatsu H, Kido J, Sawada T, Sugawara K, Misumi Y, Hayashi Y, Fujita A, Matsumoto N, Ueda M, Nakamura K. ZMYND11 p.Arg600Trp variant associated with a distinctive neurodevelopmental phenotype. Hum Genome Var. 2026;13:7.

Usuku H, Yamamoto E, Imamura K, Higashi R, Nozuhara A, Oike F, Kuyama N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Arima Y, Oda S, Kawano H, Matsuzawa Y, Izumiya Y, Ueda M, Tanaka Y, Tsujita K. Usefulness of Regional Longitudinal Strain to Identify Transthyretin Amyloid Cardiomyopathy. Circ Rep. 2025;8:495-497.

Ueda M. Lysozyme encounters transthyretin: rethinking amyloid complexity in ligamentum flavum. Amyloid. 2026;33:119-120.

Kinoshita Y, Usuku H, Yamamoto E, Mori D, Higashi R, Nozuhara A, Oike F, Kuyama N, Tabata N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Arima Y, Oda S, Kawano H, Matsuzawa Y, Izumiya Y, Ueda M, Tanaka Y, Tsujita K. Usefulness of Sinus of Valsalva Wall Thickness to Predict 99 mTc-Pyrophosphate Scintigraphy Positivity in Patients With Aortic Stenosis. Circ Rep. 2025;8:276-284.

Minami Y, Ueki K, Mito M, Torisu K, Yamada S, Tsuneyoshi S, Fujino T, Taniguchi M, Narutomi F, Tateishi Y, Oda Y, Tasaki M, Ueda M, Kitazono T, Nakano T. A Case of Amyloid Arthritis With Increased Amyloid Deposition of Both β2-Microglobulin and Transthyretin Before Reinitiating Dialysis Long After Kidney Transplantation. Nephrology (Carlton). 2026;31:e70162.

Namitome S, Kawamoto K, Nagao Y, Shindo S, Kuroki K, Hayashi H, Terasaki K, Terasaki T, Ueda M, Nakajima M. Impact of Corticospinal Tract Involvement Beyond ASPECTS on Brain Imaging Prior to Endovascular Therapy in Patients with Large Ischemic Core. Stroke Vasc Interv Neurol. 2025;5:e001818.

Harada S, Nakajima M, Nomura T, Kimura R, Matsubara S, Misumi Y, Kuyama N, Izumiya Y, Tsujita K, Kimura K, Ando Y, Ueda M. High prevalence of treatable transthyretin cardiac amyloidosis in cardioembolic stroke: the first systematic cohort study. J Neurol. 2026;273:86.

Misumi Y, Nomura T, Yamakawa S, Taguchi T, Tasaki M, Obayashi K, Yamashita T, Ando Y, Ueda M. Long-term outcome of acquired transthyretin amyloidosis. Amyloid. 2026:1-7.

Kagami A, Hashimoto N, Sasaki R, Fukushima Y, Devkota HP, Tanaka S, Wada M, Yamanaka K, Yamakawa S, Misumi S, Yokoyama T, Mizuguchi M, Sato T, Nakamura T, Kotani S, Suico MA, Kai H, Ueda M, Shuto T. Glycosidic scaffold bearing multiple galloyl moieties from pomegranate disrupts transthyretin amyloids. iScience. 2025;29:114170.

Shimamoto T, Misumi Y, Uchino K, Mori A, Motoshima T, Uchino M, Ueda M. Analysis of Clinical Characteristics and Rehabilitation Outcomes in Elderly Patients with Parkinson’s Disease: A Retrospective Study. Geriatrics (Basel). 2025;10:163.

Tawara N, Ishizaki M, Wada K, Hara K, Nagatoshi C, Fujimoto A, Kurisaki R, Nishida Y, Maeda Y, Ueda M, Ueyama H. Post-Streptococcal Myositis With Perivascular Inflammation: A Case Report. Muscle Nerve. 2026;73:910-913.

Yamamoto M, Izumiya Y, Takashio S, Morikawa K, Oguni T, Kuyama N, Oike F, Ishii M, Usuku H, Hanatani S, Matsuzawa Y, Yamamoto E, Ueda M, Tsujita K. The impact of large v-waves of pulmonary artery wedge pressure in patients with wild-type transthyretin amyloid cardiomyopathy. J Cardiol. 2026;87:221-229.

Sato T, Neshige S, Togo M, Matsubara S, Ikeda S, Yamamoto A, Ashizaki T, Ishibashi H, Ohno N, Nonaka M, Matsuura H, Katagiri M, Terasawa Y. Application of the 2HELPS2B score with short-duration EEG for seizure prediction in acute impaired consciousness: A multicenter study. J Neurol Sci. 2025;479:125665.

Imamura M, Mizutani H, Nakahara K, Ogata H, Taguchi T, Imura M, Nomura T, Misumi Y, Isobe N, Ueda M. Clinical and Radiological Heterogeneity in Anti-Neurofascin-155 Autoimmune Nodopathy: A Case Series Analysis. J Peripher Nerv Syst. 2025;30:e70077.

Nishizawa RH, Kawano H, Eguchi C, Yoshimuta T, Kojima S, Minami T, Eguchi M, Okano S, Ikeda S, Ueda M, Maemura K. Effect of β-Blockers on the Left Ventricular Strain in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy Treated With Tafamidis. Circ Rep. 2025;7:1102-1108.

Nagao Y, Singu T, Naganuma M, Inatomi Y, Hashimoto Y, Yonehara T, Shindo S, Ueda M, Nakajima M. Feasibility and Safety of a Novel 4 Fr Sheath Transradial and Transbrachial Approach for Mechanical Thrombectomy in Selected Patients. Neurol Med Chir (Tokyo). 2025;65:615-624.

Takahashi K, Sasaki D, Iwamura T, Yamamoto S, Ueda M, Yamamura N, Yoshino M, Enomoto D, Morioka H, Uemura S, Okura T, Sakaue T, Inoue K. Tracking a patient with no technetium-99m-pyrophosphate myocardial uptake at surgical valve replacement for aortic stenosis. J Geriatr Cardiol. 2025;22:828-833.

Takahashi K, Iwamura T, Hiratsuka Y, Yamamoto S, Sasaki D, Kitazawa S, Yamamura N, Ueda M, Morioka H, Uemura S, Sakaue T, Inoue K. Amyloid myopathy in the internal oblique muscle of patients with wild-type transthyretin cardiac amyloidosis. Amyloid. 2026;33:75-78.

Takahashi K, Ueda M, Utsunomiya Y, Morioka H, Uemura S, Sakaue T, Inoue K. What are the Safest and Easiest Extra-Cardiac Biopsy Sites for the Diagnosis of Wild-Type Transthyretin Cardiac Amyloidosis? Confirmation of the Diagnosis by Biopsy of the Pectoralis Muscle During Pacemaker Insertion. Eur J Case Rep Intern Med. 2025;12:005785.

Yatsuda J, Kanenawa K, Nomura T, Okada M, Masuda T, Misumi Y, Tasaki M, Ueda M, Ando Y, Kamba T. Comprehensive Histopathological and Biochemical Analyzes of Prostatic Amyloid Bodies (Corpora Amylacea) From Autopsy Samples From Japanese Patients. Prostate. 2026;86:116-123.

Kido J, Mizukami T, Misumi Y, Sugawara K, Kusunoki S, Nishimura N, Mizuguchi T, Matsumoto N, Ueda M, Nakamura K. Osteogenesis imperfecta, intellectual disability and recurrent infections in a male with a pathogenic SASH3 variant. Hum Genome Var. 2025;12:19.

Nomura T, Misumi Y, Tasaki M, Yamakawa S, Taguchi T, Obayashi K, Yamashita T, Ando Y, Ueda M. Genetic and clinical features of hereditary transthyretin amyloidosis: a decade of experience at a Japanese referral center. Orphanet J Rare Dis. 2025;20:474.

Mizutani H, Nakahara K, Harada S, Koyama S, Ueda M. Unmasking Cerebrotendinous Xanthomatosis: Clinical Recognition of a Treatable Cause of Progressive Ataxia. Neurology. 2025;105:e214099.

Nishihara T, Kawano Y, Tasaki M, Naito A, Yuki H, Nagayoshi Y, Takashio S, Nishimura N, Ueda M, Tsujita K, Yasunaga JI. Concurrent Immunoglobulin Light Chain and Transthyretin Cardiac Amyloidosis Patient Treated With Daratumumab and Tafamidis: A Case Report. EJHaem. 2025;6:e70122.

Nakamori M, Tachiyama K, Matsumura N, Hironaka A, Muraoka Y, Kitagawa T, Tasaki M, Yamakawa S, Ueda M, Maruyama H. Hereditary transthyretin amyloidosis with cardiomyopathy and polyneuropathy associated with a novel pathogenic TTR Tyr105His (p.Tyr125His) mutation. Amyloid. 2025;32:375-378.

Kuyama N, Izumiya Y, Takashio S, Usuku H, Tabira A, Ishii M, Kidoh M, Oda S, Hanatani S, Matsuzawa Y, Yamamoto E, Hirai T, Ueda M, Tsujita K. Influence of Age at Diagnosis on Clinical Disease Parameters in Wild-Type Transthyretin Amyloid Cardiomyopathy. JACC Asia. 2025;5:1202-1205.

Yamane M, Umeda H, Toyobe M, Iwai A, Ishihara K, Kudo G, Mitsunuma H, Hori Y, Tomita T, Mizuguchi M, Okada M, Ueda M, Ando Y, Kawashima SA, Sohma Y, Kaji H, Hirokawa T, Yamanaka K, Kanai M. Catalytic Photooxygenation Demonstrates Therapeutic Efficacy in Transthyretin Amyloidosis. J Am Chem Soc. 2025;147:28860-28874.

Tachibana H, Ueda M, Matsushita T. Development of Hypothyroidism in a Patient with ATTRv Amyloidosis Following Patisiran Administration. Intern Med. 2026;65:582-586.

Oike F, Usuku H, Yamamoto E, Matsukawa Y, Sueta D, Tabata N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Arima Y, Takashio S, Kawano Y, Oda S, Kawano H, Tanaka Y, Ueda M, Tsujita K. Usefulness of STREI: A new index of right heart function in patients with immunoglobulin light chain cardiac amyloidosis. Int J Cardiol. 2025;439:133646.

Eguchi C, Kawano H, Nishizawa RH, Yoshimuta T, Ohno C, Kojima S, Minami T, Sato D, Eguchi M, Okano S, Ikeda S, Ueda M, Maemura K. Comparing Effects of Tafamidis in Controlling Left Ventricular and Left Atrial Strains in Patients With Wild-Type Transthyretin Amyloid Cardiomyopathy. Circ Rep. 2025;7:562-567.

Wixner J, Dispenzieri A, Amass L, Carlsson M, Riley S, Powers E, Kelly JW; THAOS investigators. Survival in a Contemporary, Real-World Cohort of Patients with Mixed-Phenotype Transthyretin Amyloid Cardiomyopathy Treated with Tafamidis: An Analysis from THAOS. Cardiol Ther. 2025;14:583-599.

Hayashi H, Nakajima M, Inatomi Y, Terasaki T, Yonehara T, Wada K, Kouzaki Y, Yi K, Hashimoto Y, Ueda M. Stroke severity and prognosis in patients on the brink of end-stage chronic kidney disease: K-PLUS registry. J Stroke Cerebrovasc Dis. 2025;34:108391.

Taguchi T, Matsubara S, Nakahara K, Ohmori H, Ueda M. Ear and Nose Abnormalities in Meningoencephalitis Associated With Relapsing Polychondritis: A Case Report. Cureus. 2025;17:e85254.

Tawara N, Itasaka M, Horio Y, Sugahara K, Hara K, Nagatoshi C, Fujimoto A, Ishizaki M, Kurisaki R, Nisida Y, Nakamura K, Maeda Y, Ueda M, Ueyama H. Distinguishing immune checkpoint inhibitor-induced hypothyroid myopathy from myositis: a case report and review. Neuromuscul Disord. 2025;52:105420.

Takahashi K, Yoshida S, Ueda M, Uemura S, Inoue K. Wild-Type Transthyretin Amyloid Depositions in the Subcutaneous Fat and Skeletal Muscles of a Nonagenarian Who Had Heart Failure With Preserved Ejection Fraction and No Myocardial Technetium-99m-Labeled Pyrophosphate Uptake. Cureus. 2025;17:e84759.

Matsuo J, Nakahara K, Hara Y, Ueda M. Satralizumab Ameliorates Refractory Central Neuropathic Pain and Painful Tonic Spasms in Neuromyelitis Optica Spectrum Disorder: A Case Report. Cureus. 2025;17:e86335.

Higashi H, Miyazaki Y, Ueda M, Tamaki S, Nishimura K, Inoue K, Ikeda S, Yamaguchi O. Incidental acute cholecystitis as a gateway to the diagnosis of AL cardiac amyloidosis. J Cardiol Cases. 2025;31:182-185.

Konishi H, Abe H, Matsumoto N, Endo Y, Sekijima Y, Ueda M, Ando Y. Real-World Utilization Patterns, Safety, and Efficacy of Tafamidis in Patients With Hereditary Transthyretin Amyloidosis in Japan. Curr Ther Res Clin Exp. 2025;102:100793.

Koga M, Branca M, Strbian D, Yoshimoto T, Tanaka K, Yoshimura S, Yakushiji Y, Fujimoto S, Vedamurthy A, Krishnan M, Tiainen M, Vehoff J, Sibolt G, Matsuzono K, Kulyk C, Räty S, Slade P, Salerno A, Hemelsoet D, Horvath T, Kunieda T, Nakajima M, Akiyama H, Iguchi Y, Inoue M, Ihara M, Toyoda K, Seiffge D, Goeldlin M, Dawson J, Fischer U. Impact of Stroke Severity and Vascular Risk Factors on Early Versus Late Anticoagulation in Patients With Stroke and Atrial Fibrillation. J Stroke. 2025;27:284-288.

Sugita Y, Furuta T, Takahashi K, Higaki K, Koda Y, Mori SI, Hongo S, Hamasaki H, Kakita A, Ueda M, Kitagawa K. Alzheimer’s Disease With Cardiac Transthyretin Amyloidosis: A Clinicopathological Study of Autopsy Cases. Neuropathology. 2025;45:e70011.

Sugata K, Rahman A, Niimura K, Monde K, Ueno T, Rajib SA, Takatori M, Sakhor W, Hossain MB, Sithi SN, Jahan MI, Matsuda K, Ueda M, Yamano Y, Ikeda T, Ueno T, Tsuchiya K, Tanaka Y, Tokunaga M, Maeda K, Utsunomiya A, Okuma K, Ono M, Satou Y. Intragenic viral silencer element regulates HTLV-1 latency via RUNX complex recruitment. Nat Microbiol. 2025;10:1447-1462.

Misumi Y, Ando Y, Nakashima N, Sugimura Y, Shirahama R, Noguchi R, Matsuda H, Ando K, Tsunoda N, Izumiya Y, Tsujita K, Ueda M. Senescence Accelerates the Occurrence of Dual Amyloidosis: Alzheimer’s Disease and Wild-Type Transthyretin Amyloidosis. Cureus. 2025;17:e81753.

Matsuo J, Namitome S, Hara Y, Terasaki T, Nakajima M, Ueda M. Auto Immune Glial Fibrillary Acidic Protein Astrocytopathy Coexistent with Positivity for Anti-NH2-terminal of α-enolase Antibodies. Intern Med. 2025;64:3150-3154.

Ouchi K, Masuda T, Yonemaru K, Isono K, Ohya Y, Shiraki N, Tasaki M, Inomata Y, Ueda M, Era T, Kume S, Ando Y, Jono H. Dynamic changes of intracellular signals in ATTR Tyr114Cys amyloidosis. Biochem Biophys Rep. 2025;42:102012.

Hayashi H, Namitome S, Shindo S, Yoshimura S, Shirakawa M, Beppu M, Sakai N, Yamagami H, Uchida K, Toyoda K, Matsumaru Y, Matsumoto Y, Todo K, Hayakawa M, Ota S, Morimoto M, Takeuchi M, Imamura H, Ikeda H, Tanaka K, Ishihara H, Kakita H, Sano T, Araki H, Nomura T, Sakakibara F, Ueda M, Nakajima M. Effect of intravenous alteplase before endovascular therapy for atherothrombotic stroke-related large vessel occlusion: subanalysis of the RESCUE AT-LVO registry. Stroke Vasc Neurol. 2025;10:725-733.

Muchtar E, Grogan M, Aus dem Siepen F, Waddington-Cruz M, Misumi Y, Carroll AS, Clarke JO, Sanchorawala V, Milani P, Caccialanza R, Da Prat V, Pruthi R, Quintana LF, Bridoux F. Supportive care for systemic amyloidosis: International Society of Amyloidosis (ISA) expert panel guidelines. Amyloid. 2025;32:93-116.

Morikawa K, Izumiya Y, Takashio S, Kawano Y, Oguni T, Kuyama N, Oike F, Yamamoto M, Tabata N, Ishii M, Hanatani S, Hoshiyama T, Kanazawa H, Matsuzawa Y, Usuku H, Yamamoto E, Ueda M, Tsujita K. Early experience with daratumumab-containing regimens in patients with light-chain cardiac amyloidosis. J Cardiol. 2025;85:440-446.

Inatomi Y, Nakajima M, Yonehara T. Aphasic status epilepticus treated in the emergency room: A report of two cases. Cureus. 2025;17:e98642

Kimura K, Nishiyama Y, Iwasaki YK, Shimizu W, Toyoda K, Sakamoto Y, Katano T, Yamamoto T, Takeuchi M, Kumagai K, Tsuto K, Sugi K, Kusano K, Koga M, Okubo S, Sato T, Hamaguchi H, Yoshida A, Kuriki A, Tanno K, Kitagawa K, Hagiwara N, Daida H, Iguchi Y, Fujimoto S, Miyamoto S, Fukuzawa M, Sugimoto M, Takita A, Otsuka T, Okumura K. Catheter Ablation and Oral Anticoagulation for Secondary Stroke Prevention in Atrial Fibrillation: The STABLED Randomized Clinical Trial. JAMA Neurol. 2026;83:329-338.